Latest news
Eli Lilly says sales for weight-loss drugs are helping drive earnings well above expectations - WTHRWTHR · Wed, 05 Aug 2026 20:30:00 GMTGLP-1 drugs are driving higher sales for Eli Lilly and Novo Nordisk - National - Global NewsGlobal News · Wed, 05 Aug 2026 19:03:28 GMTEli Lilly Stock Rises as GLP-1 Demand Drives Beat-and-Raise - Schaeffer's Investment ResearchSchaeffer's Investment Research · Wed, 05 Aug 2026 13:21:15 GMTRising Demand for Weight Loss Drugs Drives Eli Lilly's Q2 Revenue Up 48% Year-on-Year, Full-Year Revenue Guidance Raised to $85-87 Billion|Earnings Report Insights - BitgetBitget · Wed, 05 Aug 2026 03:21:57 GMT